# Progress Note 05 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Marilyn Monroe (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML002-SYN
- Date: 2026-09-14
- Fictional facility: St. Posthumous Health Center
- Fictional author: Joanna Whitlock, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Three-month review on continuous hormonal treatment. **S**

## History of present illness

Ms. Monroe returns three months after her first visit. She has taken the continuous pill daily and has had no periods, only a day or two of light spotting each month. Her worst pelvic pain in the past week was 4 of 10, from 8, she has used naproxen on two or three days a month, and she has missed no work for two months. Pain with deep intercourse persists and makes her tense up beforehand; bowel movements are no longer painful. The urine culture from her bladder infection grew Escherichia coli sensitive to nitrofurantoin, and her HPV, HIV and hepatitis C tests from the preventive visit were negative. She has had eight therapy sessions, sleeps seven hours without any sleep aid, and feels more like herself. She has had no thoughts of suicide or self-harm. **S**

| Element | Detail |
|---|---|
| Pain | Worst 4 of 10, from 8; no missed work for two months |
| Bleeding | No periods; light spotting a day or two a month |
| Intercourse | Deep pain persists |
| Results | Urine culture E. coli; HPV, HIV and hepatitis C negative |
| Mood | PHQ-9 6, GAD-7 5; eight therapy sessions |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Gastrointestinal | Negative | No painful bowel movements; no stomach pain on naproxen |
| Genitourinary | Positive | Deep pain with intercourse; light spotting only; no urinary symptoms |
| Neurological | Negative | No migraine or visual aura |
| Psychiatric | Negative | Mood better; no thoughts of suicide or self-harm |

4 systems reviewed. **S**

## Current medications

- Naproxen 500 mg oral tablet, one tablet by mouth twice daily with food, from two days before an expected bleed until the third day, and for pain flares; no more than 10 days a month **S**
- Ethinyl estradiol 0.02 mg and norethindrone acetate 1 mg oral tablet, one tablet by mouth daily, taken continuously without a pill-free week **S**
- Folic acid 0.4 mg oral tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 114/72 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 56.8 kg; BMI 20.6 kg/m². All vital signs are synthetic.

Hemoglobin: 12.8 g/dL; PHQ-9: 6; GAD-7: 5; Pelvic pain, worst in the past week (0 to 10): 4. All results are synthetic.

## Change since baseline

- Hemoglobin: 12.2 g/dL at baseline, 12.8 g/dL at this visit **S**
- PHQ-9: 12 at baseline, 6 at this visit **S**
- GAD-7: 8 at baseline, 5 at this visit **S**
- Pelvic pain, worst in the past week (0 to 10): 8 at baseline, 4 at this visit **S**

## Immunizations given today

- Influenza vaccine, 2026-2027 season **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 114/72, pulse 72; weight 56.8 kg |
| Abdomen | Soft and non-tender |
| Pelvic | Tight, tender levator ani muscles on both sides, worse on the left, that reproduce her pain with intercourse; mild left uterosacral tenderness, less than at diagnosis; no nodule; uterus mobile |
| Psychiatric | Brighter and engaged; organized |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Endometriosis with a left ovarian endometrioma** (N80.102). Good response to continuous suppression: worst pain 4 of 10 from 8, no missed work, light spotting only, naproxen rarely needed. Blood pressure 114/72; no migraine with aura. Hemoglobin 12.8 g/dL. No reason for surgery. **S**
   - Continue the continuous combined pill.
   - Repeat transvaginal ultrasound before the next visit.
   - Influenza vaccine given today; she declined the COVID-19 vaccine for now.
2. **Pelvic floor muscle dysfunction with myofascial pain** (M62.89). The deep pain with intercourse that persists despite suppression comes largely from tight, tender pelvic floor muscles, a common companion of endometriosis pain that responds to physical therapy rather than to more hormones or surgery. **S**
   - Refer to pelvic floor physical therapy weekly for six to eight weeks.
   - A water-based lubricant and unhurried intercourse; stop if painful.
3. **Acute cystitis** (N30.00). Resolved; culture-sensitive organism treated. **S**
   - No further action.
4. **Major depressive disorder, single episode, moderate** (F32.1). PHQ-9 6 from 12, a 50% response, with cognitive behavioral therapy and better pain control; GAD-7 5. No antidepressant is needed. Safety reviewed: no thoughts of suicide or self-harm; the safety plan is current. **S**
   - Continue therapy every two weeks.
   - PHQ-9 and GAD-7 at the next visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Pelvic pain score (0 to 10), pain with intercourse and bowel movements, and missed working days | Every visit | Completed today | Worst pain 4 of 10, from 8; deep pain with intercourse; no bowel pain; no missed work for two months |
| Self-management | Bleeding pattern on continuous suppression | Every visit | Completed today | No periods; light spotting a day or two a month |
| Medication safety | Combined pill: adherence, side effects, and reasons to stop estrogen (migraine with aura, high blood pressure, clot symptoms, smoking) | Every visit, with blood pressure | Completed today | Taken daily; blood pressure 114/72; no migraine with aura or clot symptoms |
| Medication safety | Naproxen: days used each month, and stomach or kidney symptoms | Every visit | Completed today | Two or three days a month; no stomach pain |
| Medication safety | No opioid, benzodiazepine, or sleep-medicine accumulation; prescription monitoring program | At the start, then every visit while pain is active | Completed today | No opioid, benzodiazepine or sleep medicine; prescription monitoring program checked today: no new prescriptions |
| Laboratory | Hemoglobin | At baseline with heavy bleeding; again on treatment | Completed today | 12.8 g/dL, from 12.2 |
| Imaging | Transvaginal ultrasound: endometrioma size and deep disease | At diagnosis; repeat at about four months on medical treatment, then yearly or if symptoms change | Due | Repeat ultrasound booked before the next visit |
| Examination | Pelvic examination | At diagnosis, and when pain persists or changes | Completed today | Tender levator ani muscles reproduce her pain; uterosacral tenderness less |
| Referral | Surgical evaluation (laparoscopic excision) | If pain does not respond to medical treatment, the cyst grows, or imaging is atypical | Not indicated | Pain responding to medical treatment |
| Referral | Pelvic floor physical therapy | When pelvic floor muscle pain is found | Referred | Weekly for six to eight weeks |
| Self-management | Pregnancy intention and fertility plan | Every visit | Completed today | Still planning a pregnancy in about a year; folic acid daily |
| Survey | Depression measure (PHQ-9) | Monthly during acute treatment, every 2 to 4 weeks in continuation, then periodically | Deferred | PHQ-9 6 today, from 12 at intake and 8 at nine weeks. The PHQ-9 due about four weeks into treatment was not done: the only visit then was the sick visit for cystitis, and the measure was left for the preventive visit at nine weeks. No harm resulted: scores fell at each check and safety was reviewed at the sick visit. Corrective action: the behavioral health clinician records the PHQ-9 at each session and sends it to the chart |
| Survey | Anxiety measure (GAD-7) | At diagnosis and with each depression measure | Completed today | GAD-7 5, from 8 |
| Survey | Suicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; safety plan current |
| Self-management | Cognitive behavioral therapy engagement | Weekly for the first month, then every two weeks | Completed today | Eight sessions |
| Self-management | Sleep without sedatives | Every visit | Completed today | Seven hours without any sleep aid |

## Goal progress

- Worst pelvic pain 3 of 10 or less, and no missed working days for pain, by four months. In progress; target 2026-10-26. **S**
- No opioid, benzodiazepine or sleep-medicine prescription, and naproxen on 10 days a month or fewer. In progress; target 2026-10-26. **S**
- PHQ-9 score below 5 by four months. In progress; target 2026-10-26. **S**
- A written plan for when and how to try for a pregnancy, made with her before the four-month visit. In progress; target 2026-10-26. **S**

## Guideline basis

- Practice Bulletin No. 114: Management of Endometriosis (2010), American College of Obstetricians and Gynecologists (Obstetrics and Gynecology)
- ESHRE guideline: endometriosis (2022), European Society of Human Reproduction and Embryology (Human Reproduction Open)
- Chronic Pelvic Pain: ACOG Practice Bulletin, Number 218 (2020), American College of Obstetricians and Gynecologists (Obstetrics and Gynecology)
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)
- U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 (2024), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)
- U.S. Selected Practice Recommendations for Contraceptive Use, 2024 (2024), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)
- Anxiety Disorders in Adults: Screening (2023), U.S. Preventive Services Task Force
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- Adult Immunization Schedule by Medical Condition and Other Indication (2026), Centers for Disease Control and Prevention

## Follow-up

- Pelvic floor physical therapy weekly. Transvaginal ultrasound in about five weeks, then a visit to review it, with the pain score, PHQ-9 and GAD-7. **S**
- Next scheduled visit 2026-10-26: four-month review: pelvic floor physical therapy, follow-up ultrasound, mood, and pregnancy plans. **S**
